Novel HIV-1 MiRNAs stimulate TNFa release in human macrophages via TLR8 signaling pathway

PLoS ONE

Volumn 9, Issue 9, 2014, Pages

  Bernard, Mark A ^a   Zhao, Hui ^a,b   Yue, Simon C ^a   Anandaiah, Asha ^a   Koziel, Henry ^a   Tachado, Souvenir D ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b SHANXI MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CELL EXTRACT; MICRORNA; MICRORNA 88; MICRORNA 99; MICRORNA TAR; TOLL LIKE RECEPTOR 8; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; OLIGONUCLEOTIDE; VIRUS RNA;

ARTICLE; CELL FRACTIONATION; CONTROLLED STUDY; CYTOKINE RELEASE; DNA STRUCTURE; ENZYME LINKED IMMUNOSORBENT ASSAY; EXOSOME; G+U BASE COMPOSITION; GENETIC CONSERVATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LUNG ALVEOLUS MACROPHAGE; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SEQUENCE; SIGNAL TRANSDUCTION; BIOLOGICAL MODEL; BIOSYNTHESIS; CELL LINE; CHEMISTRY; CONFORMATION; DNA BASE COMPOSITION; DRUG EFFECTS; GENE SILENCING; GENETICS; IMMUNOLOGY; MACROPHAGE; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; RNA INTERFERENCE; SEQUENCE ALIGNMENT; VIROLOGY;

BASE COMPOSITION; BASE SEQUENCE; CELL LINE; CONSERVED SEQUENCE; EXOSOMES; GENE SILENCING; HIV INFECTIONS; HIV-1; HUMANS; MACROPHAGES; MACROPHAGES, ALVEOLAR; MICRORNAS; MODELS, BIOLOGICAL; MOLECULAR SEQUENCE DATA; NUCLEIC ACID CONFORMATION; OLIGONUCLEOTIDES; RNA INTERFERENCE; RNA, VIRAL; SEQUENCE ALIGNMENT; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 8; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84934785332     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0106006     Document Type: Article

References (49)

1. Bosinger SE, Sodora DL, Silvestri G (2011) Generalized immune activation and innate immune responses in simian immunodeficiency virus infection. Curr Opin HIV AIDS 6: 411-418.
2. Anthony KB, Yoder C, Metcalf JA, DerSimonian R, Orenstein JM, et al. (2003) Incomplete CD4 T cell recovery in HIV-1 infection after 12 months of highly active antiretroviral therapy is associated with ongoing increased CD4 T cell activation and turnover. J Acquir Immune Defic Syndr 33: 125-133.
3. Brenchley JM, Price DA, Schacker TW, Asher TE, Silvestri G, et al. (2006) Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med 12: 1365-1371.
4. Sodora DL, Silvestri G (2008) Immune activation and AIDS pathogenesis. AIDS 22: 439-446.
5. Silvestri G, Feinberg MB (2003) Turnover of lymphocytes and conceptual paradigms in HIV infection. J Clin Invest 112: 821-824.
6. Hasegawa A, Liu H, Ling B, Borda JT, Alvarez X, et al. (2009) The level of monocyte turnover predicts disease progression in the macaque model of AIDS. Blood 114: 2917-2925.
7. Calin GA, Croce CM (2006) MicroRNA signatures in human cancers. Nat Rev Cancer 6: 857-866.
8. Han X, Li X, Yue SC, Anandaiah A, Hashem F, et al. (2012) Epigenetic regulation of tumor necrosis factor a (TNFa) release in human macrophages by HIV-1 single-stranded RNA (ssRNA) is dependent on TLR8 signaling. J Biol Chem 287: 13778-13786.
9. Lehmann SM, Kruger C, Park B, Derkow K, Rosenberger K, et al. (2012) An unconventional role for miRNA: let-7 activates Toll-like receptor 7 and causes neurodegeneration. Nat Neurosci 15: 827-835.
10. Virtue A, Wang H, Yang XF (2012) MicroRNAs and Toll-like receptor/interleukin-1 receptor signaling. J Hematol Oncol 5: 66.
11. Pegtel DM, Cosmopoulos K, Thorley-Lawson DA, vanEijndhoven MA, Hopmans ES, et al. (2010) Functional delivery of viral miRNAs via exosomes. Proc Natl Acad Sci U S A 107: 6328-6333.
12. Pfeffer S, Sewer A, Lagos-Quintana M, Sheridan R, Sander C, et al. (2005) Identification of microRNAs of the herpesvirus family. Nat Methods 2: 269-276.
13. Yeung ML, Bennasser Y, Watashi K, Le SY, Houzet L, et al. (2009) Pyrosequencing of small non-coding RNAs in HIV-1 infected cells: Evidence for the processing of a viral-cellular double-stranded RNA hybrid. Nucleic Acids Res 37: 6575-6586.
14. Schopman NC, Willemsen M, Liu YP, Bradley T, vanKampen A, et al. (2012) Deep sequencing of virus-infected cells reveals HIV-encoded small RNAs. Nucleic Acids Res 40: 414-427.
15. Whisnant AW, Bogerd HP, Flores O, Ho P, Powers JG, et al. (2013) In-depth analysis of the interaction of HIV-1 with cellular microRNA biogenesis and effector mechanisms. MBio 4(2): E000193.
16. Narayanan A, Iordanskiy S, Das R, Van Duyne R, Santos S, et al. (2013) Exosomes derived from HIV-1-infected cells contain trans-activation response element RNA. J Biol Chem 288: 20014-20033.
17. Aquaro S, Bagnarelli P, Guenci T, De Luca A, Clementi M, et al. (2002) Longterm survival and virus production in human primary macrophages infected by human immunodeficiency virus. J Med Virol 68: 479-488.
18. Kinter AL, Poli G, Maury W, Folks TM, Fauci AS (1990) Direct and cytokinemediated activation of protein kinase C induces human immunodeficiency virus expression in chronically infected promonocytic cells. J Virol 64: 4306-4312.
19. Klebanoff SJ, Mehlin C, Headley CM (1997) Activation of the HIV type 1 long terminal repeat and viral replication by dimethylsulfoxide and related solvents. AIDS Res Hum Retroviruses 13: 1221-1227.
20. Pasternak AO, de Bruin M, Jurriaans S, Bakker M, Berkhout B, et al. (2012) Modest nonadherence to antiretroviral therapy promotes residual HIV-1 replication in the absence of virological rebound in plasma. J Infect Dis 206: 1443-1452.
21. Vandergeeten C, Quivy V, Moutschen M, Van Lint C, Piette J, et al. (2007) HIV-1 protease inhibitors do not interfere with provirus transcription and host cell apoptosis induced by combined treatment TNF-a+TSA. Biochem Pharmacol 73: 1738-1748.
22. Tachado SD, Li X, Bole M, Swan K, Anandaiah A, et al. (2010) MyD88- dependent TLR4 signaling is selectively impaired in alveolar macrophages from asymptomatic HIV+ persons. Blood 115: 3606-3615.
23. Tachado SD, Zhang J, Zhu J, Patel N, Koziel H (2005) HIV impairs TNFa release in response to Toll-like receptor 4 stimulation in human macrophages in vitro. Am J Respir Cell Mol Biol 33: 610-621.
24. Koziel H, Eichbaum Q, Kruskal BA, Pinkston P, Rogers RA, et al. (1998) Reduced binding and phagocytosis of Pneumocystis carinii by alveolar macrophages from persons infected with HIV-1 correlates with mannose receptor downregulation. J Clin Invest 102: 1332-1344.
25. Garbati MR, Hays LE, Keeble W, Yates JE, Rathbun RK, et al. (2013) FANCA and FANCC modulate TLR and p38 MAPK-dependent expression of IL-1b in macrophages. Blood 122: 3197-3205.
26. Bunn RC, Cockrell GE, Ou Y, Thrailkill KM, Lumpkin CK Jr., et al. (2010) Palmitate and insulin synergistically induce IL-6 expression in human monocytes. Cardiovasc Diabetol 9: 73.
27. Pfaffl MW (2001) A new mathematical model for relative quantification in Real- Time RT-PCR. Nucleic Acids Res 29: E45.
28. Markham NR, Zuker M (2008) UNAFold: Software for nucleic acid folding and hybridization. Methods Mol Biol 453: 3-31.
29. Böhnlein S, Hauber J, Cullen BR (1989) Identification of a U5-specific sequence required for efficient polyadenylation within the human immunodeficiency virus long terminal repeat. J Virol 63: 421-424.
30. Das AT, Klaver B, Berkhout B (1999) A hairpin structure in the R region of the human immunodeficiency virus type 1 RNA genome is instrumental in polyadenylation site selection. J Virol 73: 81-91.
31. Forsbach A, Nemorin JG, Montino C, Müller C, Samulowitz U, et al. (2008) Identification of RNA sequence motifs stimulating sequence-specific TLR8- dependent immune responses. J Immunol 180: 3729-3738.
32. Althaus CF, Vongrad V, Niederöst B, Joos B, DiGiallonardo F, et al. (2012) Tailored enrichment strategy detects low abundant small noncoding RNAs in HIV-1 infected cells. Retrovirology 9: 27.
33. Klase Z, Winograd R, Davis J, Carpio L, Hildreth R, et al. (2009) HIV-1 TAR miRNA protects against apoptosis by altering cellular gene expression. Retrovirology 6: 18.
34. Tanji H, Ohto U, Shibata T, Miyake K, Shimizu T (2013) Structural reorganization of the Toll-like receptor 8 dimer induced by agonistic ligands. Science 339: 1426-1429.
35. Bernard MA, Han X, Inderbitzin S, Agbim I, Zhao H, et al. (2014) HIV-derived ssRNA binds to TLR8 to induce inflammation-driven macrophage foam cell formation. PLoS ONE 9(8): E104039.
36. Berkhout B, Klaver B, Das AT (1995) A conserved hairpin structure predicted for the poly(A) signal of human and simian immunodeficiency viruses. Virology 207: 276-281.
37. Klasens BI, Thiesen M, Virtanen A, Berkhout B (1999) The ability of the HIV-1 AAUAAA signal to bind polyadenylation factors is controlled by local RNA structure. Nucleic Acids Res 27: 446-454.
38. Stroynowski I, Kuroda M, Yanofsky C (1983) Transcription termination in vitro at the tryptophan operon attenuator is controlled by secondary structures in the leader transcript. Proc Natl Acad Sci U S A 80: 2206-2210.
39. Yanofsky C (2000) Transcription attenuation: once viewed as a novel regulatory strategy. J Bacteriol 182: 1-8.
40. Turnbough CL Jr., Switzer RL (2008) Regulation of pyrimidine biosynthetic gene expression in bacteria: Repression without repressors. Microbiol Mol Biol Rev 72: 266-300.
41. Wagschal A, Rousset E, Basavarajaiah P, Contreras X, Harwig A, et al. (2012) Microprocessor, Setx, Xrn2, and Rrp6 co-operate to induce premature termination of transcription by RNAPII. Cell 150: 1147-1157.
42. Morelli AE, Larregina AT, Shufesky WJ, Sullivan ML, Stolz DB, et al. (2004) Endocytosis, intracellular sorting, and processing of exosomes by dendritic cells. Blood 104: 3257-3266.
43. Bennasser Y, Le SY, Benkirane M, Jeang KT (2005) Evidence that HIV-1 encodes an siRNA and a suppressor of RNA silencing. Immunity 22: 607-619.
44. Brown BD, Gentner B, Cantore A, Colleoni S, Amendola M, (2007) Endogenous microRNA can be broadly exploited to regulate transgene expression according to tissue, lineage and differentiation state. Nat Biotechnol 25: 1457-1467.
45. Dölken L, Perot J, Cognat V, Alioua A, John M, et al. (2007) Mouse cytomegalovirus microRNAs dominate the cellular small RNA profile during lytic infection and show features of posttranscriptional regulation. J Virol 81: 13771-13782.
46. Ouellet DL, Vigneault-Edwards J, Létourneau K, Gobeil LA, Plante I, et al. (2013) Regulation of host gene expression by HIV-1 TAR microRNAs. Retrovirology 10: 86.
47. Schopman NC, van Montfort T, Willemsen M, Knoepfel SA, Pollakis G, et al. (2012) Selective packaging of cellular miRNAs in HIV-1 particles. Virus Res 169: 438-447.
48. Robbins M, Judge A, Liang L, McClintock K, Yaworski E, et al. (2007) 29-Omethyl- modified RNAs act as TLR7 antagonists. Mol Ther 15: 1663-1669.
49. Hamm S, Latz E, Hangel D, Müller T, Yu P, et al. (2010) Alternating 29-Oribose methylation is a universal approach for generating non-stimulatory siRNA by acting as TLR7 antagonist. Immunobiology 215: 559-569.